HLA-типирование

Список публикаций по применению технологии x-MAP

• HLA-типирование
• Анализ профиля экспрессии генов
• Биосинтез белка
• Генетические заболевания
• Генотипирование
• Заболевания, вызванные инфекционными молекулами
• Защита от биологического оружия / Экология
• Иммунодиагностика
• Технология

Akalin E, Bromberg JS, 2005, Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients.  Hum Immunol., 66(4):359-63

Akalin E, Sehgal V, Murphy B, Akalin E, Sehgal V, Ames S, Bromberg JS, Murphy B, Dikman S, Fotino M, 2005, Intravenous immunoglobulin treatment in a kidney transplant patien twith chronic allograft nephropathy  TRANSPLANTATION, 79(2):257-8

Arnold ML, Pei R, Spriewald B, Wassmuth R, 2005, Anti-HLA class II antibodies in kidney retransplant patients.  Tissue Antigens, 65(4):370-8

Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, 2005, Transplantation of 2 partially HLA-matched umbilical cord blood unitsto enhance engraftment in adults with hematologic malignancy  BLOOD, 105(3):1343-7

Cillo U, Vitale A, Brolese A, Zanus G, Bassanello M, Montin U, D'Amico F, Ciarleglio FA, Iurilli V, Carraro P, Grigoletto F, Plebani M, D'Amico DF, 2005, Syngeneic living-donor liver transplantation for hemangioendothelioma: a clinical model for studying liver regeneration.  Am J Transplant., 5(9):2309-14

Colovai AI, Vasilescu ER, Foca-Rodi A, Kim-Schulze S, Hussaini N, D'agati VD, Markowitz GS, Wang C, Cohen DJ, Hardy MA, Suciu-Foca N, 2005, Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.  Hum Immunol, 66(5):501-12

Fontaine MJ, Malone J, Mullins FM, Grumet FC, 2006, Diagnosis of Transfusion-Related Acute Lung Injury: TRALI or Not TRALI?  Ann Clin Lab Sci., 36(1):53-8

Hack N, Angra S, McKnight TL, den Hollander N, Cardella CJ, 2005, Abnormal B-cell regulation in highly sensitized patients with sustained serum levels of antibody to HLA class I antigens.  Transplantation, 80(9):1226-32

Han M, Tan YQ, Zhang Y, Tsai J, Vorhaben R, Moraes JR, Moraes ME, Stastny P, 2003, Multiplex single nucleotide extension: a robust and high throughput method for HLA-A locus typing.  HUMAN IMMUNOLOGY, 64(12):1111-22

Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD, 2005, Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.  J Am Soc Nephrol., 16(9):2804-12

Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M, Inoko H, 2005, High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.  Immunogenetics, 57(10):717-29

Kirk AD, Mannon RB, Kleiner DE, Swanson JS, Kampen RL, Cendales LK, Elster EA, Wakefield T, Chamberlain C, Hoffmann SC, Hale DA, 2005, Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation, 80(8):1051-9

Kushihata F, Watanabe J, Mulder A, Claas F, Scornik JC, 2004, Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential.  Transplantation, 78(7):995-1001

Miao KR, Pan QQ, Xue M, Zhou XY, Fei XM, Tang YH, Xu R, Zhang JW, Zhao X, Osowski L, Shi WX, Xu AL, Wang CY, KuKuruga D, 2005, A novel HLA allele, DRB1*1609, identified in the Chinese Han population*.  Tissue Antigens., 66(3):248-50

Miao KR, Xue M, Zhou XY, Xu R, Fei XM, Pan QQ, Zhang JW, Zhao X, Fan S, KuKuruga D, Xu AL, Wang CY, 2006, Characterization of a novel DRB1*14 allele (DRB1*1449) in the Han-Chinese population.  Int J Immunogenet., 33(1):33-5

Mizutani K, Terasaki P, Rosen A, Esquenazi V, Miller J, Shih RN, Pei R, Ozawa M, Lee J, 2005, Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure.  Am J Transplant. , 5(9):2265-72

Morales-Buenrostro LE, Buzo-Romero JM, de Leo C, Lopez M, Ortiz-Arroyo VM, Perez-Garrido J, Herrera-Garcia C, Granados J, Alberu J, 2006, Prevalence of HLA Antibodies and Its Impact on Graft Function in a Group of Kidney Transplant Recipients: A Cross-Sectional Study.  Transplant Proc. , 38(3):899-902

Muro M, Llorente S, Marin L, Moya-Quiles MR, Gonzalez-Soriano MJ, Prieto A, Gimeno L, Alvarez-Lopez MR, 2005, Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRATM, ELISA and CDC vs luminex screening.  Nephrolology Dialysis Transplantation, 20: 223-226

Onizuka M, Yoshikawa E, Inoko H, 2005, [HLA typing and transplantation]  Nippon Rinsho, 63(11):1945-9

Rostron A, Carter V, Mutunga M, Cavanagh G, O'Suilleabhain C, Burt A, Jaques B, Talbot D, Manas D, 2005, A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil.  Transpl Int, 18(11):1298-301

Shaddy RE, Fuller TC, Anderson JB, Lambert LM, Brinkman MK, Profaizer T, Hawkins JA, 2004, Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation.  Ann Thorac Surg., 77(5):1734-9

Smith DM, Baker JE, Gardner WB, Martens GW, Agura ED, 2005, HLA class I null alleles and new alleles affect unrelated bone marrow donor searches.  Tissue Antigens., 66(2):93-8

Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S, 2006, A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.  Am J Transplant., 6(2):346-51

Tamura M, Yamada A, Takao Y, Matsueda S, Komatsu N, Yutani S, Ide T, Sata M, Itoh K, 2005, Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.  Hepatol Res, Epub ahead of p

Toy P, Hollis-Perry KM, Jun J, Nakagawa M, 2004, Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.  TRANSFUSION, 44(12):1683-8

Voorter CE, de Groot NG, Meertens CM, Bontrop RE, van den Berg-Loonen EM, 2005, Allelic polymorphism in introns 1 and 2 of the HLA-DQA1 gene.  TISSUE ANTIGENS, 65(1):56-66

Watanabe J, Scornik JC, 2005, IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity.  Am J Transplant., 5(11):2786-90

Yan LX, Zhu FM, Lv QF, Zhang HQ, Zhang W, He J, 2005, Identification of a new HLA-B*56 variant, B*5614.  Tissue Antigens, 65(3):278-9

Yan LX, Zhu FM, Lv QF, Zhang W, Zhang HQ, He J, 2005, Identification of HLA-B*5136 in the Chinese population.  Tissue Antigens., 65(3):280-2

Zachary AA, Montgomery RA, Leffell MS, 2005, Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.  Hum Immunol, 66(4):364-70

Zhang Q, Liang LW, Gjertson DW, Lassman C, Wilkinson AH, Kendrick E, Pham PT, Danovitch GM, Gritsch HA, Reed EF, 2005, Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction.  Transplantation, 79(5):591-8